Anticancer activity of thymoquinone against breast cancer cells: Mechanisms of action and delivery approaches.

[1]  A. A. El-Shehawy,et al.  Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches , 2023, BMC Complementary Medicine and Therapies.

[2]  Yayin Fang,et al.  Thymoquinone effect on the Dictyostelium discoideum model correlates with functional roles for glutathione S-transferases in eukaryotic proliferation, chemotaxis, and development , 2023, PloS one.

[3]  Khaled S. Allemailem,et al.  Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice , 2022, Journal of inflammation research.

[4]  Mohammed A. Alsahli,et al.  Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer , 2022, Pharmaceutics.

[5]  S. Hamid,et al.  Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles , 2021, International journal of molecular sciences.

[6]  T. Gratieri,et al.  Polymeric nanocapsules: a review on design and production methods for pharmaceutical purpose. , 2021, Methods.

[7]  H. Gali-Muhtasib,et al.  Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells , 2021, World journal of clinical oncology.

[8]  D. Cordato,et al.  The role of thymoquinone, a major constituent of Nigella sativa, in the treatment of inflammatory and infectious diseases , 2021, Clinical and experimental pharmacology & physiology.

[9]  Junjiang Fu,et al.  Synergistic Role of Thymoquinone on Anticancer Activity of 5-fluorouracil in Triple-Negative Breast Cancer Cells. , 2021, Anti-cancer agents in medicinal chemistry.

[10]  S. Mousa,et al.  Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. , 2021, Nanomedicine.

[11]  M. Asif,et al.  Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments , 2021, Drug delivery.

[12]  K. Wadher,et al.  Development of topical thymoquinone loaded polymer–lipid hybrid vesicular gel: in-vitro and ex-vivo evaluation , 2021, Journal of liposome research.

[13]  Jie Liang,et al.  Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development , 2021, Cancer biology & medicine.

[14]  Khaled S. Allemailem,et al.  Safety and Therapeutic Efficacy of Thymoquinone-Loaded Liposomes against Drug-Sensitive and Drug-Resistant Acinetobacter baumannii , 2021, Pharmaceutics.

[15]  R. Khan,et al.  Thymoquinone-Loaded Nanocarriers for Healthcare Applications , 2021 .

[16]  H. A. Al-Jamal,et al.  Thymoquinone, as a Novel Therapeutic Candidate of Cancers , 2021, Pharmaceuticals.

[17]  R. Rahbarghazi,et al.  Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells , 2021, BMC Complementary Medicine and Therapies.

[18]  A. Sultan,et al.  Abstract PS19-28: Thymoquinone and tamoxifen co-treatment synergistically inhibit proliferation, invasion and induce apoptosis in human breast cancer cell lines in vitro and in vivo , 2021 .

[19]  Rizwanullah,et al.  Effect of Chitosan Coating on PLGA Nanoparticles for Oral Delivery of Thymoquinone: In Vitro, Ex Vivo, and Cancer Cell Line Assessments , 2020, Coatings.

[20]  K. Pal,et al.  Guar gum micro-vehicle mediated delivery strategy and synergistic activity of thymoquinone and piperine: An in vitro study on bacterial and hepatocellular carcinoma cells , 2020 .

[21]  H. Gali-Muhtasib,et al.  Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization , 2020, International journal of nanomedicine.

[22]  Mohammed S. Alqahtani,et al.  Development, Characterization Optimization, and Assessment of Curcumin-Loaded Bioactive Self-Nanoemulsifying Formulations and Their Inhibitory Effects on Human Breast Cancer MCF-7 Cells , 2020, Pharmaceutics.

[23]  D. Chowdhury,et al.  Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use , 2020, International journal of nanomedicine.

[24]  M. Shakibaei,et al.  An Overview of the Role of Adipokines in Cardiometabolic Diseases , 2020, Molecules.

[25]  Hana M. Gashlan,et al.  Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells , 2020, Scientific Reports.

[26]  Khalid Rehman Hakeem,et al.  An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties , 2020, Journal of Herbal Medicine.

[27]  C. Zhong,et al.  Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism With Clinical Therapeutics and Dependence of p53 Status , 2020, Frontiers in Pharmacology.

[28]  Suhair Sunoqrot,et al.  Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture , 2020, Pharmaceutics.

[29]  Yihan Yao,et al.  Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance , 2020, Frontiers in Molecular Biosciences.

[30]  O. Ahmed,et al.  Thymoquinone Loaded Zein Nanoparticles Improves the Cytotoxicity against Breast Cancer Cells , 2020 .

[31]  S. Mousa,et al.  Thymoquinone and Costunolide Induce Extensive Apoptosis of Senescent Colon and Senescent Breast Cancer Cells , 2020 .

[32]  M. Hasnain,et al.  Lipid based nano carriers for cancer and tumor treatment. , 2020, Current pharmaceutical design.

[33]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[34]  R. Thangam,et al.  Synergetic effects of thymoquinone-loaded porous PVPylated Fe3O4 nanostructures for efficient pH-dependent drug release and anticancer potential against triple-negative cancer cells , 2020, Nanoscale advances.

[35]  N. Alhakamy,et al.  Preparation and Characterization of Chitosan Coated PLGA Nanoparticles of Resveratrol: Improved Stability, Antioxidant and Apoptotic Activities in H1299 Lung Cancer Cells , 2020, Coatings.

[36]  R. Censi,et al.  Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities , 2020, Nanomaterials.

[37]  K. Pal Facile Synthesis of Natural Therapeutics Encapsulated Biopolymeric Okra Mucilage Nanoparticles as Dual ameliorative agent , 2020 .

[38]  D. Chellappan,et al.  Nanocarriers: more than tour de force for thymoquinone , 2020, Expert opinion on drug delivery.

[39]  M. Mesbah,et al.  Stability study of thymoquinone, carvacrol and thymol using HPLC-UV and LC-ESI-MS , 2020, Acta pharmaceutica.

[40]  M. Rahaie,et al.  Thymoquinone-loaded ethosome with breast cancer potential: optimization, in vitro and biological assessment , 2020, Journal of Nanostructure in Chemistry.

[41]  M. Raish,et al.  Gender effect on the pharmacokinetics of thymoquinone: Preclinical investigation and in silico modeling in male and female rats , 2020, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[42]  R. P,et al.  In vitro studies to analyze the stability and bioavailability of thymoquinone encapsulated in the developed nanocarrier , 2020, Journal of Dispersion Science and Technology.

[43]  P. Ranjekar,et al.  Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice , 2020, Frontiers in Pharmacology.

[44]  S. Akhter,et al.  Co-encapsulation of Docetaxel and Thymoquinone in mPEG-DSPE-Vitamin E TPGS-Lipid nanocapsules for breast cancer therapy: Formulation Optimization and Implications on cellular and in vivo toxicity. , 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  A. M. Al-Abd,et al.  Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism , 2020, Molecules.

[46]  S. Mousa,et al.  Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone , 2020, Integrative cancer therapies.

[47]  A. Sattar,et al.  Pharmacokinetics of thymoquinone in layer chickens following oral and intravenous administration. , 2019, Journal of veterinary pharmacology and therapeutics.

[48]  W. Alshaer,et al.  Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel , 2019, Heliyon.

[49]  F. Ahmad,et al.  Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies. , 2019, Colloids and surfaces. B, Biointerfaces.

[50]  Junjiang Fu,et al.  Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics. , 2019, Drug discovery today.

[51]  Rajesh Singh,et al.  Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway , 2019, Cancers.

[52]  N. Nordin,et al.  Ultrastructural Changes and Antitumor Effects of Doxorubicin/Thymoquinone-Loaded CaCO3 Nanoparticles on Breast Cancer Cell Line , 2019, Front. Oncol..

[53]  H. Abdelrazek,et al.  Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[54]  A. M. Al-Abd,et al.  Abstract 2995: Thymoquinone attenuates breast cancer cell resistance to paclitaxel via targeting tumor associated stem cell population , 2019, Experimental and Molecular Therapeutics.

[55]  Ki‐Hyun Kim,et al.  Antidiabetic activity enhancement in streptozotocin + nicotinamide–induced diabetic rats through combinational polymeric nanoformulation , 2019, International journal of nanomedicine.

[56]  Ebrahim M Yimer,et al.  Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses , 2019, Evidence-based complementary and alternative medicine : eCAM.

[57]  M. Mirzaei,et al.  Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay , 2019, Scientific Reports.

[58]  Arif Khan,et al.  Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells , 2019, Asian Pacific journal of cancer prevention : APJCP.

[59]  I. Badea,et al.  Polymeric Nanoparticles in Gene Therapy: New Avenues of Design and Optimization for Delivery Applications , 2019, Polymers.

[60]  S. Hamid,et al.  Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells. , 2018, Advances in experimental medicine and biology.

[61]  M. R. Mozafari,et al.  Enhanced efficacy and bioavailability of thymoquinone using nanoliposomal dosage form , 2018, Journal of Drug Delivery Science and Technology.

[62]  G. Karimi,et al.  An overview of in vivo toxicological profile of thymoquinone , 2018, Toxin Reviews.

[63]  S. Mousa,et al.  Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases , 2018, Nutrients.

[64]  A. M. Al-Abd,et al.  Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities , 2018, Scientific Reports.

[65]  S. Jacob,et al.  Cyclodextrin complexes: Perspective from drug delivery and formulation , 2018, Drug development research.

[66]  Chau Dang,et al.  Overview of Breast Cancer Therapy. , 2018, PET clinics.

[67]  Wei Keat Ng,et al.  Thymoquinone loaded in nanostructured lipid carrier showed enhanced anticancer activity in 4T1 tumor-bearing mice. , 2018, Nanomedicine.

[68]  Bo Liu,et al.  Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis , 2018, Genes & diseases.

[69]  T. Farkhondeh,et al.  The Neuroprotective Effects of Thymoquinone: A Review , 2018, Dose-response : a publication of International Hormesis Society.

[70]  Jingyuan Wen,et al.  Nanostructured Lipid Carriers , 2018 .

[71]  I. Pathan,et al.  Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study , 2018 .

[72]  D. Choi,et al.  Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders , 2018, Oxidative medicine and cellular longevity.

[73]  P. Maiti,et al.  Controlled drug delivery vehicles for cancer treatment and their performance , 2018, Signal Transduction and Targeted Therapy.

[74]  H. Gali-Muhtasib,et al.  Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. , 2018, Drug discovery today.

[75]  E. Wasan,et al.  An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery , 2017, Pharmaceutics.

[76]  M. Akram,et al.  Awareness and current knowledge of breast cancer , 2017, Biological Research.

[77]  Chandragouda R. Patil,et al.  Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin , 2017, Front. Pharmacol..

[78]  T. Webster,et al.  Elastic liposomes as novel carriers: recent advances in drug delivery , 2017, International journal of nanomedicine.

[79]  Wamidh H. Talib Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone , 2017, Scientia pharmaceutica.

[80]  M. Raish,et al.  Oral bioavailability enhancement and hepatoprotective effects of thymoquinone by self-nanoemulsifying drug delivery system. , 2017, Materials science & engineering. C, Materials for biological applications.

[81]  M. I. Khan,et al.  Hybrid Nano-carriers for Potential Drug Delivery , 2017 .

[82]  Xiangshan Chen,et al.  Self-assembled nanocapsules in water: a molecular mechanistic study. , 2017, Physical chemistry chemical physics : PCCP.

[83]  Naser Karimi,et al.  Application of Various Types of Liposomes in Drug Delivery Systems , 2017, Advanced pharmaceutical bulletin.

[84]  M. Boskabady,et al.  Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review. , 2016, Journal of ethnopharmacology.

[85]  J. Ferdous,et al.  Thymoquinone is Knocking at the Door of Clinical Trial , 2016 .

[86]  T. Viitala,et al.  Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation , 2016, AAPS PharmSciTech.

[87]  Ranjita Shegokar,et al.  Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications , 2016, Expert opinion on drug delivery.

[88]  Banu Iskender,et al.  The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer , 2016, Tumor Biology.

[89]  N. Sharma,et al.  Exploring versatile applications of cyclodextrins: an overview , 2016, Drug delivery.

[90]  Michael R Hamblin,et al.  Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials. , 2016, International journal of advanced research.

[91]  Banu Iskender,et al.  Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway? , 2016, Tumor Biology.

[92]  P. Fisher,et al.  Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes. , 2015, Molecular pharmaceutics.

[93]  Ajaz Ahmad,et al.  Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model , 2015, European Journal of Drug Metabolism and Pharmacokinetics.

[94]  M. Raish,et al.  Effects of Thymoquinone on the Pharmacokinetics and Pharmacodynamics of Glibenclamide in a Rat Model , 2015, Natural product communications.

[95]  S. Mirhafez,et al.  Thymoquinone Ameliorates Acute Renal Failure in Gentamicin-Treated Adult Male Rats , 2015, Pharmacology.

[96]  M. Hashemi,et al.  The Comparison of Anticancer Activity of Thymoquinone and Nanothymoquinone on Human Breast Adenocarcinoma , 2015, Iranian journal of pharmaceutical research : IJPR.

[97]  A. Alzohairy,et al.  Health-promoting value and food applications of black cumin essential oil: an overview , 2015, Journal of Food Science and Technology.

[98]  M. Mandal,et al.  Thymoquinone Restores Radiation‐Induced TGF‐β Expression and Abrogates EMT in Chemoradiotherapy of Breast Cancer Cells , 2015, Journal of cellular physiology.

[99]  Xiaoyang Xu,et al.  Cancer Nanomedicine: From Targeted Delivery to Combination Therapy , 2015, Trends in molecular medicine.

[100]  K. Tikoo,et al.  Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy , 2015, Journal of Nanoparticle Research.

[101]  Wei Keat Ng,et al.  Thymoquinone-Loaded Nanostructured Lipid Carrier Exhibited Cytotoxicity towards Breast Cancer Cell Lines (MDA-MB-231 and MCF-7) and Cervical Cancer Cell Lines (HeLa and SiHa) , 2015, BioMed research international.

[102]  Seon-Mi Yu,et al.  The thymoquinone-induced production of reactive oxygen species promotes dedifferentiation through the ERK pathway and inflammation through the p38 and PI3K pathways in rabbit articular chondrocytes , 2014, International journal of molecular medicine.

[103]  S. Samarghandian,et al.  Preventive effect of safranal against oxidative damage in aged male rat brain , 2014, Experimental animals.

[104]  Dongming Qi,et al.  Recent advances in the preparation of hybrid nanoparticles in miniemulsions. , 2014, Advances in colloid and interface science.

[105]  S. Aly,et al.  Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways , 2014, Evidence-based complementary and alternative medicine : eCAM.

[106]  Huixia Lv,et al.  Aqueous Solubility and Degradation Kinetics of the Phytochemical Anticancer Thymoquinone; Probing the Effects of Solvents, pH and Light , 2014, Molecules.

[107]  A. A. Martens,et al.  The multiple facets of drug resistance: one history, different approaches , 2014, Journal of experimental & clinical cancer research : CR.

[108]  Rupesh Dudhe,et al.  Nanoemulsion: an advanced mode of drug delivery system , 2014, 3 Biotech.

[109]  V. Saini,et al.  Formulation and Characterization of Drug Loaded Nonionic Surfactant Vesicles (Niosomes) for Oral Bioavailability Enhancement , 2014, TheScientificWorldJournal.

[110]  R. Abu-Dahab,et al.  Preparation, characterization and antiproliferative activity of thymoquinone-beta-cyclodextrin self assembling nanoparticles. , 2013, Die Pharmazie.

[111]  Marjaneh Motaghed,et al.  Thymoquinone regulates gene expression levels in the estrogen metabolic and interferon pathways in MCF7 breast cancer cells , 2013, International journal of molecular medicine.

[112]  F. Khanum,et al.  Thymoquinone-loaded PLGA nanoparticles: antioxidant and anti-microbial properties , 2013 .

[113]  G. Sethi,et al.  Thymoquinone Inhibits Tumor Growth and Induces Apoptosis in a Breast Cancer Xenograft Mouse Model: The Role of p38 MAPK and ROS , 2013, PloS one.

[114]  Ç. Şakalar,et al.  Pronounced transcriptional regulation of apoptotic and TNF–NF-kappa-B signaling genes during the course of thymoquinone mediated apoptosis in HeLa cells , 2013, Molecular and Cellular Biochemistry.

[115]  Marjaneh Motaghed,et al.  Cellular responses with thymoquinone treatment in human breast cancer cell line MCF-7 , 2013, Pharmacognosy research.

[116]  T. Collares,et al.  Developments in the use of nanocapsules in oncology , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[117]  Doman Kim,et al.  Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava , 2013, Bioorganic & Medicinal Chemistry.

[118]  I. Suzuki,et al.  Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity. , 2013, Biochemical and biophysical research communications.

[119]  P. Fisher,et al.  Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer , 2013, PloS one.

[120]  S. Aly,et al.  The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy. , 2013, International journal of clinical and experimental medicine.

[121]  W. Khalil,et al.  Evaluation of the protective effect of Nigella sativa extract and its primary active component thymoquinone against DMBA-induced breast cancer in female rats , 2013, Archives of medical science : AMS.

[122]  Ajaz Ahmad,et al.  HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY OF THYMOQUINONE IN RABBIT PLASMA AND ITS APPLICATION TO PHARMACOKINETICS , 2013 .

[123]  K. Allison,et al.  Computer aided detection , 2000, Breast Cancer Research.

[124]  G. Mustafa,et al.  Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study , 2012, International journal of nanomedicine.

[125]  R. Abu-Dahab,et al.  Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer , 2012, Drug delivery.

[126]  A. Pichette,et al.  ANTIOXIDANT, ANTI‐INFLAMMATORY, ANTICANCER AND ANTIBACTERIAL ACTIVITIES OF EXTRACTS FROM NIGELLA SATIVA (BLACK CUMIN) PLANT PARTS , 2012 .

[127]  F. Tanfani,et al.  Characterization of thymoquinone binding to human α₁-acid glycoprotein. , 2012, Journal of pharmaceutical sciences.

[128]  G. Colditz,et al.  Family history and risk of breast cancer: nurses’ health study , 2012, Breast Cancer Research and Treatment.

[129]  Anders Axelsson,et al.  The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review. , 2011, International journal of pharmaceutics.

[130]  F Atyabi,et al.  Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents , 2011, International journal of nanomedicine.

[131]  Jun Jie Wang,et al.  Recent advances of chitosan nanoparticles as drug carriers , 2011, International journal of nanomedicine.

[132]  R. Schobert,et al.  Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin , 2011, Cancer Chemotherapy and Pharmacology.

[133]  G. Wani,et al.  Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. , 2011, Mutation research.

[134]  F. Tanfani,et al.  Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[135]  I. Warner,et al.  Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles , 2010, Nanotechnology.

[136]  G. Kulkarni,et al.  Nanoemulsion: A new concept of delivery system , 2010 .

[137]  Cui Tang,et al.  Folate-mediated solid–liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol) , 2010, Drug development and industrial pharmacy.

[138]  P. Eckl,et al.  Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. , 2010, Journal of ethnopharmacology.

[139]  R. Schneider-Stock,et al.  Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling , 2010, Apoptosis.

[140]  F. Meng,et al.  Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. , 2009, Biomaterials.

[141]  J. Benoit,et al.  Lipid nanocapsules: a new platform for nanomedicine. , 2009, International journal of pharmaceutics.

[142]  M. Nagi,et al.  Thymoquinone supplementation induces quinone reductase and glutathione transferase in mice liver: possible role in protection against chemical carcinogenesis and toxicity , 2009, Phytotherapy research : PTR.

[143]  Zhiwei Wang,et al.  Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer. , 2009, Cancer research.

[144]  A. Al-Amri,et al.  PHASE I SAFETY AND CLINICAL ACTIVITY STUDY OF THYMOQUINONE IN PATIENTS WITH ADVANCED REFRACTORY MALIGNANT DISEASE , 2009 .

[145]  Mingyao Liu,et al.  Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways , 2008, Molecular Cancer Therapeutics.

[146]  B. Aggarwal,et al.  Targeting Nuclear Factor-κB Activation Pathway by Thymoquinone: Role in Suppression of Antiapoptotic Gene Products and Enhancement of Apoptosis , 2008, Molecular Cancer Research.

[147]  M. Menon,et al.  Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. , 2007, Cancer research.

[148]  Y. N. Park,et al.  DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. , 2007, International journal of molecular medicine.

[149]  G. Lupidi,et al.  Nonenzymatic reduction of thymoquinone in physiological conditions , 2007, Free radical research.

[150]  V. Pillay,et al.  Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. , 2005, International journal of pharmaceutics.

[151]  R. Goldbohm,et al.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.

[152]  R. Löbenberg,et al.  Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[153]  J. Bolton,et al.  Role of quinones in toxicology. , 2000, Chemical research in toxicology.

[154]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[155]  G. Shadab,et al.  Low doses of thymoquinone protect isolated human blood cells from TiO2 nanoparticles induced oxidative stress, hemolysis, cytotoxicity, DNA damage and collapse of mitochondrial activity , 2021 .

[156]  Soha Gomaa,et al.  Combination treatment of thymoquinone-loaded gold nanoparticles and cisplatin potentiates anti-tumor activity and immunomodulatory effects in breast cancer model - , 2018 .

[157]  Prabhanjan S. Giram,et al.  Ethosome: A Novel Drug Carrier , 2013 .

[158]  P. Eckl,et al.  In vitro toxicological properties of thymoquinone. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[159]  S. Haque,et al.  Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome , 2008, International journal of diabetes in developing countries.

[160]  Aamir Ahmad,et al.  From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. , 2008, Cancer therapy.

[161]  R. Schneider-Stock,et al.  The medicinal potential of black seed (Nigella sativa) and its components , 2006 .

[162]  P. Dudrick,et al.  In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. , 2003, International journal of oncology.

[163]  Jingliang Cheng,et al.  Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition. , 2015, Oncotarget.